NYSE:USNA USANA Health Sciences (USNA) Stock Price, News & Analysis â The Best AI Stock to Own in the World Today is Trading for Just $25 (From Banyan Hill Publishing) (Ad) Free usna Stock Alerts $45.55 +4.03 (+9.71%) (As of 05/1/2024 ET) Add Compare Share Share Today's Range$44.36âŒ$47.0050-Day Range$41.50âŒ$50.1752-Week Range$41.45âŒ$69.60Volume126,322 shsAverage Volume81,034 shsMarket Capitalization$876.38 millionP/E Ratio13.80Dividend YieldN/APrice Target$48.00 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Get USANA Health Sciences alerts: Email Address USANA Health Sciences MarketRank™ Stock AnalysisAnalyst RatingModerate Buy2.50 Rating ScoreUpside/Downside5.4% Upside$48.00 Price TargetShort InterestHealthy2.31% of Float Sold ShortDividend StrengthN/ASustainability-2.03Upright™ Environmental ScoreNews Sentiment0.21Based on 20 Articles This WeekInsider TradingSelling Shares$1.20 M Sold Last QuarterProj. Earnings Growth14.65%From $2.73 to $3.13 Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.3.10 out of 5 starsMedical Sector344th out of 926 stocksMedicinals & Botanicals Industry1st out of 11 stocks 1.3 Analyst's Opinion Consensus RatingUSANA Health Sciences has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 1 buy rating, 1 hold rating, and no sell ratings.Amount of Analyst CoverageUSANA Health Sciences has only been the subject of 1 research reports in the past 90 days. Previous Next 3.0 Short Interest Percentage of Shares Shorted2.31% of the float of USANA Health Sciences has been sold short.Short Interest Ratio / Days to CoverUSANA Health Sciences has a short interest ratio ("days to cover") of 3.1, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in USANA Health Sciences has recently increased by 4.50%, indicating that investor sentiment is decreasing. Previous Next 0.0 Dividend Strength Dividend YieldUSANA Health Sciences does not currently pay a dividend.Dividend GrowthUSANA Health Sciences does not have a long track record of dividend growth. Previous Next 3.0 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreUSANA Health Sciences has received a 27.31% net impact score from Upright. The largest positive contribution comes from its "Nutrition" impact, which is mostly driven by its "Direct selling of nutritional products through representatives", "Direct selling of dietary supplements through representatives", and "Direct selling of skincare products through representatives" products. See details.Environmental SustainabilityThe Environmental Impact score for USANA Health Sciences is -2.03. Previous Next 1.8 News and Social Media Coverage News SentimentUSANA Health Sciences has a news sentiment score of 0.21. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.35 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 20 news articles for USANA Health Sciences this week, compared to 2 articles on an average week.MarketBeat FollowsOnly 2 people have added USANA Health Sciences to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, USANA Health Sciences insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $1,200,791.00 in company stock.Percentage Held by InsidersOnly 0.33% of the stock of USANA Health Sciences is held by insiders.Percentage Held by Institutions54.25% of the stock of USANA Health Sciences is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 2.5 Earnings and Valuation Earnings GrowthEarnings for USANA Health Sciences are expected to grow by 14.65% in the coming year, from $2.73 to $3.13 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of USANA Health Sciences is 13.80, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 147.34.Price to Earnings Ratio vs. SectorThe P/E ratio of USANA Health Sciences is 13.80, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 263.86.Price to Earnings Growth RatioUSANA Health Sciences has a PEG Ratio of 1.31. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioUSANA Health Sciences has a P/B Ratio of 1.75. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad Crypto Swap ProfitsClaim Your Complimentary Bitcoin RewardMany have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.Secure Your Spot Now About USANA Health Sciences Stock (NYSE:USNA)USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products. It also provides Celavive, a skin care regimen for various skin care types and ethnicities; and other products for prenatal, infant, and young child age groups. In addition, the company offers materials and online tools to assist associates in building their businesses, as well as in marketing products. It offers its products through retail stores and online. The company has a research collaboration agreement with Beijing University of Chinese Medicine; and National Sports Training Bureau. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah.Read More USNA Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart USNA Stock News HeadlinesMay 1, 2024 | finance.yahoo.comUSANA (USNA) Stock Trades Up, Here Is WhyApril 30, 2024 | markets.businessinsider.comUSNA Stock Earnings: Usana Health Sciences Beats EPS, Beats Revenue for Q1 2024May 1, 2024 | Porter & Company (Ad)Trumpâs last act as President Youâve probably never heard of Executive Order #13972. Signed by President Trump just days before leaving office, it greenlit what could be the most revolutionary technology of the decade⊠yet it has nothing to do with AI, blockchain, or mRNA vaccines. April 30, 2024 | wsj.comUSANA Health Sciences Inc.April 30, 2024 | markets.businessinsider.comUSANA Health Sciences Q1 Income Drops, but beats estimatesApril 30, 2024 | finance.yahoo.comUSANA Health Sciences Reports First Quarter 2024 ResultsApril 30, 2024 | finance.yahoo.comUSANA (NYSE:USNA) Posts Q1 Sales In Line With EstimatesApril 30, 2024 | finance.yahoo.comUsana Health Sciences Inc (USNA) Q1 2024 Earnings: Mixed Results Amidst Global ChallengesMay 1, 2024 | Porter & Company (Ad)Trumpâs last act as President Youâve probably never heard of Executive Order #13972. Signed by President Trump just days before leaving office, it greenlit what could be the most revolutionary technology of the decade⊠yet it has nothing to do with AI, blockchain, or mRNA vaccines. April 30, 2024 | seekingalpha.comUSANA Health Sciences Q1 2024 Earnings PreviewApril 29, 2024 | markets.businessinsider.comUSANA Health Sciences earnings preview: what to expectApril 29, 2024 | finance.yahoo.comEarnings To Watch: USANA (USNA) Reports Q1 Results TomorrowApril 29, 2024 | prnewswire.comUSANA Releases 2023 Sustainability ReportApril 28, 2024 | nasdaq.comCommit To Buy USANA Health Sciences At $22.50, Earn 6% Annualized Using OptionsApril 25, 2024 | prnewswire.comUSANA Honored with Local Healthy Worksite AwardApril 25, 2024 | finance.yahoo.comIs USANA Health Sciences, Inc. (NYSE:USNA) Potentially Undervalued?April 23, 2024 | americanbankingnews.comUSANA Health Sciences (USNA) Set to Announce Earnings on TuesdayApril 10, 2024 | businesswire.comUSANA Schedules First Quarter 2024 Earnings Release and Conference CallApril 9, 2024 | prnewswire.comUSANA Cements Itself as a Premier Cellular Nutrition Company in South KoreaApril 8, 2024 | finance.yahoo.comUSANA Health Sciences, Inc. (NYSE:USNA) has caught the attention of institutional investors who hold a sizeable 49% stakeApril 2, 2024 | finance.yahoo.comKevin Guest Says This Spring Cultivate a Growth Mindset: The Essential Soft Skill for Business Success in 2024March 25, 2024 | finance.yahoo.comSome Investors May Be Worried About USANA Health Sciences' (NYSE:USNA) Returns On CapitalMarch 16, 2024 | finance.yahoo.comUSNA Apr 2024 45.000 putMarch 11, 2024 | finance.yahoo.comUsana Health Sciences Inc (USNA) Executive Chairman of the Board Kevin Guest Sells 11,011 SharesMarch 6, 2024 | finance.yahoo.comUsana Health Sciences Inc (USNA) Chief Scientific Officer Robert Sinnott Sells Company SharesMarch 4, 2024 | finance.yahoo.comUsana Health Sciences Inc's Chief Legal Officer Joshua Foukas Sells Company SharesFebruary 28, 2024 | prnewswire.comKevin Guest Says Leap Forward on Leap DaySee More Headlines Receive USNA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for USANA Health Sciences and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings2/06/2024Today5/01/2024Next Earnings (Estimated)7/23/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Medicinals & botanicals Sub-IndustryPersonal Products Current SymbolNYSE:USNA CUSIP90328M10 CIK896264 Webwww.usana.com Phone(801) 954-7100Fax801-954-7300Employees1,800Year FoundedN/APrice Target and Rating Average Stock Price Target$48.00 High Stock Price Target$48.00 Low Stock Price Target$48.00 Potential Upside/Downside+5.4%Consensus RatingModerate Buy Rating Score (0-4)2.50 Research Coverage2 Analysts Profitability EPS (Most Recent Fiscal Year)$3.30 Trailing P/E Ratio13.80 Forward P/E Ratio16.68 P/E Growth1.31Net Income$63.79 million Net Margins6.93% Pretax Margin11.12% Return on Equity13.49% Return on Assets10.45% Debt Debt-to-Equity RatioN/A Current Ratio3.52 Quick Ratio3.00 Sales & Book Value Annual Sales$921.01 million Price / Sales0.95 Cash Flow$4.66 per share Price / Cash Flow9.77 Book Value$25.99 per share Price / Book1.75Miscellaneous Outstanding Shares19,240,000Free Float19,178,000Market Cap$876.38 million OptionableOptionable Beta0.91 7 Stocks to Own Before the 2024 ElectionLooking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isnât viable. So where should investors put their money? Find out with this report.Get This Free Report Key ExecutivesMr. Kevin G. Guest (Age 61)Executive Chairman Comp: $1.08MMr. Jim Brown (Age 55)CEO & President Comp: $910.73kMr. G. Douglas Hekking (Age 54)Chief Financial Officer Comp: $638.34kMr. Walter Noot (Age 58)Chief Operating Officer Comp: $623.77kMr. P. Joshua Foukas (Age 48)Chief Legal Officer, General Counsel & Corporate Secretary Comp: $561.28kMr. Daniel A. Macuga Jr. (Age 54)Chief Communications & Marketing Officer Comp: $563kDr. Myron W. Wentz (Age 83)Founder & Chairman Emeritus Dr. John CuomoExecutive Director of Product Development & TechnologyDr. Robert A. Sinnott M.N.S. (Age 59)Ph.D., Chief Scientific Officer Mr. Patrique RichardsExecutive Director of Investor Relations & Business DevelopmentMore ExecutivesKey CompetitorsMind Medicine (MindMed)NASDAQ:MNMDAurora CannabisNASDAQ:ACBCronos GroupNASDAQ:CRONbioteNASDAQ:BTMDChromaDexNASDAQ:CDXCView All CompetitorsInsiders & InstitutionsBNP Paribas Financial MarketsBought 5,952 shares on 5/1/2024Ownership: 0.202%Allspring Global Investments Holdings LLCSold 13,082 shares on 4/30/2024Ownership: 0.004%Principal Financial Group Inc.Sold 2,415 shares on 4/29/2024Ownership: 0.301%Yousif Capital Management LLCSold 470 shares on 4/26/2024Ownership: 0.026%New York State Teachers Retirement SystemSold 700 shares on 4/25/2024Ownership: 0.066%View All Insider TransactionsView All Institutional Transactions USNA Stock Analysis - Frequently Asked Questions Should I buy or sell USANA Health Sciences stock right now? 2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for USANA Health Sciences in the last twelve months. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" USNA shares. View USNA analyst ratings or view top-rated stocks. What is USANA Health Sciences' stock price target for 2024? 2 brokerages have issued 12 month price targets for USANA Health Sciences' stock. Their USNA share price targets range from $48.00 to $48.00. On average, they anticipate the company's share price to reach $48.00 in the next twelve months. This suggests a possible upside of 5.4% from the stock's current price. View analysts price targets for USNA or view top-rated stocks among Wall Street analysts. How have USNA shares performed in 2024? USANA Health Sciences' stock was trading at $53.60 at the beginning of 2024. Since then, USNA stock has decreased by 15.0% and is now trading at $45.55. View the best growth stocks for 2024 here. When is USANA Health Sciences' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, July 23rd 2024. View our USNA earnings forecast. How were USANA Health Sciences' earnings last quarter? USANA Health Sciences, Inc. (NYSE:USNA) issued its earnings results on Tuesday, February, 6th. The company reported $0.87 EPS for the quarter, topping the consensus estimate of $0.52 by $0.35. The business had revenue of $221.08 million for the quarter, compared to analysts' expectations of $206.70 million. USANA Health Sciences had a trailing twelve-month return on equity of 13.49% and a net margin of 6.93%. What ETFs hold USANA Health Sciences' stock? ETFs with the largest weight of USANA Health Sciences (NYSE:USNA) stock in their portfolio include Invesco S&P SmallCap Consumer Staples ETF (PSCC) and Global X Health & Wellness ETF (BFIT). What guidance has USANA Health Sciences issued on next quarter's earnings? USANA Health Sciences updated its FY 2024 earnings guidance on Tuesday, April, 30th. The company provided EPS guidance of 2.400-3.000 for the period, compared to the consensus EPS estimate of 2.720. The company issued revenue guidance of $850.0 million-$920.0 million, compared to the consensus revenue estimate of $889.8 million. What is Kevin Guest's approval rating as USANA Health Sciences' CEO? 68 employees have rated USANA Health Sciences Chief Executive Officer Kevin Guest on Glassdoor.com. Kevin Guest has an approval rating of 99% among the company's employees. This puts Kevin Guest in the top 10% of approval ratings compared to other CEOs of publicly-traded companies. What other stocks do shareholders of USANA Health Sciences own? Based on aggregate information from My MarketBeat watchlists, some companies that other USANA Health Sciences investors own include International Business Machines (IBM), Gilead Sciences (GILD), NVIDIA (NVDA), AT&T (T), BioMarin Pharmaceutical (BMRN), Vertex Pharmaceuticals (VRTX), AbbVie (ABBV), Walt Disney (DIS), Intuitive Surgical (ISRG) and Johnson & Johnson (JNJ). Who are USANA Health Sciences' major shareholders? USANA Health Sciences' stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Assenagon Asset Management S.A. (0.43%), Principal Financial Group Inc. (0.30%), West Coast Financial LLC (0.23%), BNP Paribas Financial Markets (0.20%), Denali Advisors LLC (0.13%) and New York State Teachers Retirement System (0.07%). Insiders that own company stock include Brent Neidig, Daniel A Macuga, David Mulham Mulham, Frederic J Winssinger, G Doug Iiekking, Gilbert A Fuller, Gilbert A Fuller, Jim Brown, John Turman Fleming, Joshua Foukas, Kevin Guest, Paul A Jones, Robert A Sinnott, Robert A Sinnott, Robert Auciaux, Walter Noot and Xia Ding. View institutional ownership trends. How do I buy shares of USANA Health Sciences? Shares of USNA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NYSE:USNA) was last updated on 5/1/2024 by MarketBeat.com Staff From Our Partnersđ± This phenomenon is smashing regular market gainsMillPubBiden to Launch âFedNOWâ [Move Your Money Now]Priority GoldHave You Seen Elonâs New A.I. Device? (Picture Inside)InvestorPlaceDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsA.I. is a Tidal Wave - Hereâs What to BuyChaikin AnalyticsForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingPOTUS in â25 Not Biden/Trump, ButThe Freeport Society4 coins to be the âNext BitcoinâTrue Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding USANA Health Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
